118 related articles for article (PubMed ID: 11165943)
1. Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption.
Violette SM; Guan W; Bartlett C; Smith JA; Bardelay C; Antoine E; Rickles RJ; Mandine E; van Schravendijk MR; Adams SE; Lynch BA; Shakespeare WC; Yang M; Jacobsen VA; Takeuchi CS; Macek KJ; Bohacek RS; Dalgarno DC; Weigele M; Lesuisse D; Sawyer TK; Baron R
Bone; 2001 Jan; 28(1):54-64. PubMed ID: 11165943
[TBL] [Abstract][Full Text] [Related]
2. A Src SH2 selective binding compound inhibits osteoclast-mediated resorption.
Violette SM; Shakespeare WC; Bartlett C; Guan W; Smith JA; Rickles RJ; Bohacek RS; Holt DA; Baron R; Sawyer TK
Chem Biol; 2000 Mar; 7(3):225-35. PubMed ID: 10712930
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity.
Shakespeare W; Yang M; Bohacek R; Cerasoli F; Stebbins K; Sundaramoorthi R; Azimioara M; Vu C; Pradeepan S; Metcalf C; Haraldson C; Merry T; Dalgarno D; Narula S; Hatada M; Lu X; van Schravendijk MR; Adams S; Violette S; Smith J; Guan W; Bartlett C; Herson J; Iuliucci J; Weigele M; Sawyer T
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9373-8. PubMed ID: 10944210
[TBL] [Abstract][Full Text] [Related]
4. High-affinity Src-SH2 ligands which do not activate Tyr(527)-phosphorylated Src in an experimental in vivo system.
Mandine E; Jean-Baptiste V; Vayssière B; Gofflo D; Bénard D; Sarubbi E; Deprez P; Baron R; Superti-Furga G; Lesuisse D
Biochem Biophys Res Commun; 2002 Oct; 298(2):185-92. PubMed ID: 12387813
[TBL] [Abstract][Full Text] [Related]
5. L-Plastin Phosphorylation: Possible Regulation by a TNFR1 Signaling Cascade in Osteoclasts.
Chellaiah MA
Cells; 2021 Sep; 10(9):. PubMed ID: 34572081
[TBL] [Abstract][Full Text] [Related]
6. Characterization of unique functionalities in c-Src domains required for osteoclast podosome belt formation.
Matsubara T; Addison WN; Kokabu S; Neff L; Horne W; Gori F; Baron R
J Biol Chem; 2021; 296():100790. PubMed ID: 34019873
[TBL] [Abstract][Full Text] [Related]
7. The SH2 domain: versatile signaling module and pharmaceutical target.
Machida K; Mayer BJ
Biochim Biophys Acta; 2005 Feb; 1747(1):1-25. PubMed ID: 15680235
[TBL] [Abstract][Full Text] [Related]
8. Src binds cortactin through an SH2 domain cystine-mediated linkage.
Evans JV; Ammer AG; Jett JE; Bolcato CA; Breaux JC; Martin KH; Culp MV; Gannett PM; Weed SA
J Cell Sci; 2012 Dec; 125(Pt 24):6185-97. PubMed ID: 23097045
[TBL] [Abstract][Full Text] [Related]
9. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
Wang B; Lemay S; Tsai S; Veillette A
Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo suppression of osteoclast function by adenovirus vector-induced csk gene.
Miyazaki T; Takayanagi H; Isshiki M; Takahashi T; Okada M; Fukui Y; Oda H; Nakamura K; Hirai H; Kurokawa T; Tanaka S
J Bone Miner Res; 2000 Jan; 15(1):41-51. PubMed ID: 10646113
[TBL] [Abstract][Full Text] [Related]
11. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
Duong LT; Lakkakorpi PT; Nakamura I; Machwate M; Nagy RM; Rodan GA
J Clin Invest; 1998 Sep; 102(5):881-92. PubMed ID: 9727056
[TBL] [Abstract][Full Text] [Related]
12. Novel bone-targeted Src tyrosine kinase inhibitor drug discovery.
Shakespeare WC; Metcalf CA; Wang Y; Sundaramoorthi R; Keenan T; Weigele M; Bohacek RS; Dalgarno DC; Sawyer TK
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):729-41. PubMed ID: 14579523
[TBL] [Abstract][Full Text] [Related]
13. A novel phosphotyrosine mimetic 4'-carboxymethyloxy-3'-phosphonophenylalanine (Cpp): exploitation in the design of nonpeptide inhibitors of pp60(Src) SH2 domain.
Kawahata N; Yang MG; Luke GP; Shakespeare WC; Sundaramoorthi R; Wang Y; Johnson D; Merry T; Violette S; Guan W; Bartlett C; Smith J; Hatada M; Lu X; Dalgarno DC; Eyermann CJ; Bohacek RS; Sawyer TK
Bioorg Med Chem Lett; 2001 Sep; 11(17):2319-23. PubMed ID: 11527723
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling.
Uehara S; Udagawa N; Mukai H; Ishihara A; Maeda K; Yamashita T; Murakami K; Nishita M; Nakamura T; Kato S; Minami Y; Takahashi N; Kobayashi Y
Sci Signal; 2017 Aug; 10(494):. PubMed ID: 28851822
[TBL] [Abstract][Full Text] [Related]
15. Src homology 2 (SH2)-containing 5'-inositol phosphatase localizes to podosomes, and the SH2 domain is implicated in the attenuation of bone resorption in osteoclasts.
Yogo K; Mizutamari M; Mishima K; Takenouchi H; Ishida-Kitagawa N; Sasaki T; Takeya T
Endocrinology; 2006 Jul; 147(7):3307-17. PubMed ID: 16601135
[TBL] [Abstract][Full Text] [Related]
16. c-Src control of chloride channel support for osteoclast HCl transport and bone resorption.
Edwards JC; Cohen C; Xu W; Schlesinger PH
J Biol Chem; 2006 Sep; 281(38):28011-22. PubMed ID: 16831863
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption.
Reddy S; Devlin R; Menaa C; Nishimura R; Choi SJ; Dallas M; Yoneda T; Roodman GD
J Cell Physiol; 1998 Dec; 177(4):636-45. PubMed ID: 10092216
[TBL] [Abstract][Full Text] [Related]
18. The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice.
Aoki K; Didomenico E; Sims NA; Mukhopadhyay K; Neff L; Houghton A; Amling M; Levy JB; Horne WC; Baron R
Bone; 1999 Sep; 25(3):261-7. PubMed ID: 10495129
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of the phosphatase PTPROt at Tyr
Roth L; Wakim J; Wasserman E; Shalev M; Arman E; Stein M; Brumfeld V; Sagum CA; Bedford MT; Tuckermann J; Elson A
Sci Signal; 2019 Jan; 12(563):. PubMed ID: 30622194
[TBL] [Abstract][Full Text] [Related]
20. Dynamin forms a Src kinase-sensitive complex with Cbl and regulates podosomes and osteoclast activity.
Bruzzaniti A; Neff L; Sanjay A; Horne WC; De Camilli P; Baron R
Mol Biol Cell; 2005 Jul; 16(7):3301-13. PubMed ID: 15872089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
